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Evidence that an HLA-DQAI-DQBI haplotype influences
susceptibility to childhood common acute lymphoblastic
leukaemia in boys provides further support for an
infection-related aetiology
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Summary Comparison of DOA1 and DOB1 alleles in 60 children with common acute tymphoblastic leukaemia (c-ALL) and 78 newborn infant
control subjects revealed that male but not female patients had a higher frequency of DA1*0A101/'O104 and DOB1*0501 than appropriate
control subjects. The results suggest a male-associated susceptibility haplotype in c-ALL and supports an infectious aetiology.
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Evidence suggesting that childhood common acute lymphoblastic
leukaemia (c-ALL) may have an infectious aetiology (reviewed by
Greaves. 1997) continues to accumulate. Associations with
socioeconomic status (Alexander et al. 1990). time-space case
clustering (Alexander. 1992). population isolation and mixing
(reviewed by Kinlen. 1995). parental occupation (Kinlen. 1997)
and seasonality (Badrinath et al. 1997: Westerbeek et al 1998) all
point to factors affecting the transmission of an infectious agent.
However, no leukaemogenic infectious agent has yet been identi-
fied in c-ALL.
Results suggestingr that infectious diseases may be no more
common in children before the development ofALL than they are
in normal children (van Steensel-Moll et al. 1986) imply that the
immune response may itself contribute to the aetiology of c-ALL
(Greaves. 1988: Greaves and Alexander. 1993). If differences in
the efficiency ofsuch immune responses do influence the risk ofc-
ALL. this may be related to the differential antigen-presenting
capacity of HLA class H alleles. We previously showed that chil-
dren with c-ALL typed more frequently for HLA-DQBI *0501
than control subjects (Dearden et al. 1996). As DQBI is very
tightly linked to DQAJ. we carried out a molecular analysis of
DQAI alleles in patients previously typed for DQBI to see ifboth
tgenes influenced susceptibility to c-ALL.
MATERIALS AND METHODS
Patients and control subjects
The patients consisted of an unselected series of 60 children (38
boys. 22 girls) with c-ALL from the same series as described
previously (Dearden et al. 1996). Control blood samples were
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obtained from the umbilical cords of 78 normal full-term newborn
infants (38 boys and 40 girls) delivered at St Marys Hospital.
HLA-DQA1 molecular typing
Genomic DNA was extracted from patient and control blood
samples as previously described (Dearden et al. 1996). and DQAI
typing carried out as described by Noreen et al (1992). A 228-bp
exon 2 fragment ofDQAI was amplified by the polymerase chain
reaction (PCR) using the primers DQAAMP-A (5'-ATG GTG
TAA ACT ACC AGT-3') and DQAAMP-B (5'-TTG GTA GCA
GCG GTA GAG T1G-3'). obtained from the British Society for
Histocompatibility and Immunogenetics (BSHI). PCR mixtures
consisted of 50 no of genomic DNA. 0.5 Em of each primer and
0.3 mi dNTPs in 20 jl of PCR buffer. Amplifications (32 cycles)
were carried out on a Thermal Cycler (Appligene. France). and
PCR products dot-blotted onto nylon filters. which were
hybridized with ten 18-mer sequence-specific oligonucleotide
(SSO) probes (from BSHI) end-labelled with Y'P-ATP. detecting
eight DQAI alleles [*0101 (*0101 + *0104). *0102. *0103.
*0201. *03 (*03011 + *0302). *0401. *05 (*05011 + *0502 +
*0503) and *0601]. The filters were scanned for radioactivity on
an InstantImager (Canberra Packard. Berks. UK). Positive
hybridization was scored by comparing test vs negyative control
spots (typically a tenfold difference in counts). DQAI alleles were
assigned by comparing SSO patterns with published information
(see Marsh reference to Website). The following pairs of alleles
could not be distinguished from each other with the probes used in
this study: *0101 from *0104: *03011 from *0302 and subtypes of
*05: *0601 homozygotes gave the same result as *0401/*0601
heterozycotes: and *0103 homozygotes gave the same result as
*0102*0103 heterozygotes.
DOB1 molecular typing
Patients and control subjects were typed for DQBI alleles by
single-strand conformation polymorphism (SSCP) analysis as
described previously (Dearden et al. 1996).
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Table 1 HLA-DQA 1 allele frequencies in childhood common ALL compared with infant control subjects
Total Males Females
Allele DQA1
group allele c-ALLb Ingfat ORc 95% Cl c-ALL Infant OR 95% Cl c-ALL Infant OR 95% Cl
101 0101/0104 18.31 9.0 2.27 1.12-4.52 21.8 6.4 4.06 1.42-10.17 11.4 11.3 1.01 0.35-3.10
0102 11.7 15.4 0.72 0.37-1.47 9.0 17.9 0.45 0.19-1.17 15.9 12.5 1.32 0.5-3.62
*0103 8.3 5.1 1.68 0.67-4.14 7.7 5.1 1.54 0.45-4.89 9.1 5.0 1.90 0.52-6.90
*0102/"103 2.5 0.6 3.97 0.56-17.14 2.6 0 - - 2.3 1.3 1.83 0.25-13.43
combined *01 40.8e 30.1 1.60 0.97-2.62 41.0 29.5 1.66 0.86-3.17 38.6 30.0 1.46 0.69-3.13
C02 *0201 12.5' 21.2 0.53 0.28-1.04 11.5 24.4 0.40 0.18-0.96 13.6 17.5 0.74 0.29-2.06
'03 combined '03 22.59 15.4 1.59 0.87-2.90 23.1 10.3 2.62 1.07-6.02 20.5 20.0 1.02 0.43-2.52
*04 *0401 2.5 1.3 1.97 0.4-8.38 0 2.6 0 - 6.8 0 - -
0401/0601 0.8 0 - - 1.3 0 - - 0 0 - -
'05 20.8 31.4 0.57 0.34-1.0 20.5 30.8 0.58 0.29-1.20 20.5 31.3 0.56 0.25-1.35
10601 0 0.6 0 0.04-4.8 0 0 0 - 0 1.3 - 0.05-6.75
combined *04 24.2 33.3 0.63 0.38-1.09 21.8 33.3 0.55 0.28-1.14 27.3 32.5 0.77 0.36-1.74
nr-- 60 78 38 38 22 40
aDQA10101 and *0104 were not distinguished with the SSO probes used here. Heterozygotes with DQA1*0102/0103 and .0401/e0601 could not be
distinguished. Combined *03alklees include '03011 and *0302. bResults are allele frequencies (%). COR, odds ratos; 95% Cl, 95% confidence interval.
aD2A1 0101/eO104. total ALL vs total infant control subjects: two-sided Fishers P = 0.03. Male c-ALL vs male infant control subjects: two-sided Fisher's
P = 0.01. eCombined DQA1 01 alleles: total c-ALL vs total control subjects: two-sided Fisher's P = 0.08. Male c-ALL vs male control subjects: two-sided Fisher's
P= 0.18. fDQA10201: total c-ALL vs total control subjects: two-sided Fisher's P= 0.08. Male c-ALL vs male control subjects: two-sided Fisher's P= 0.05.
gCombined IXQA1'03alleles: total c-ALL vs total control subjects: two-sided Fisher's P = 0.17. Male c-ALL vs male control subjects: two-sided Fisher's P = 0.05.
In, number of subjects in each group.
Data analysis
Differences in patient and control allele frequencies are expressed
as odds ratios (OR) (Altman. 1991) together with 95% confidence
intervals (CI) derived using Miettinens method (Breslow and Day.
1980). Patient and control DQAI allele frequencies were also
compared using 2 x 2 analysis. and tested for significance by two-
sided Fisher's exact tests. DQAl and DQB1 exon 2 polymorphic
amino acid frequencies (see Marsh) were compared in patients and
control subjects using ORs and 2 x 2 tests. Observed and expected
heterozygosity was compared using allelic diversity (h) (Nei and
Roychoudhury, 1974). Sample size (i.e. statistical power) calcula-
tions were performed using nQuery Advisorrelease 2.0 (Statistical
Solutions. Cork. Ireland).
RESULTS
Study group
The patients consisted of a prospective series of 38 boys and 22
girls with c-ALL aged between 1.6 and 12.9 years, with a mean
age at diagnosis of 5 years 3 months, and a median of 4 years 4
months. There was a 26% excess of male to female patients.
giving an M:F of 1.73:1. The mean (median) age of the male
patients was 4 years 8 months (4 years 3 months), compared with
the mean (median) age of the female patients of 6 years 2 months
(4 years 10 months).
HLA-DQA1 alleles in c-ALL
All DQAJ alleles detected in the c-ALL patients were also found
in the infant control subjects. Analysis of heterozygosity (h)
showed no significant difference between observed and expected
values for c-ALL (obs.. 71.%: exp.. 66.4%. P = 0.22) and infant
control subjects (obs.. 66.7%: exp. 75.5%:c P = 0.22) or between
c-ALL and control subjects.
Table 1 shows thatDQAI*01 was more frequent in patients than
control subjects (OR = 1.60: 95%c CI: 0.97-2.62). mainly because
ofDQAI*0101/*0104 (OR = 2.27: 1.12-4.52). There was also an
increase in the DQAI*03 (OR = 1.59: 0.87-2.90) and a deficit in
DQAI*0201 (OR = 0.53: 0.28-1.04).
Male c-ALL had a significantly higher frequency of
DQAI*0101/*0104 (OR = 4.06: 1.42-10.17) (Table 1). a higher
frequency of DQAJ*03 (OR = 2.62: 1.07-6.02) and a deficit of
DQAI*0201 (OR = 0.40: 0.18-0.96) than male control subjects.
Apart from a small deficit in DQAJ *0201. there were no differ-
ences between female c-ALL and female control subjects.
DOA1 and DOB1 alleles in c-ALL
Patients and control subjects were classified according to whether
they typed for both DQBI *0501 and DQAJ *01011*0104. Table 2
shows that the greatest difference was between male c-ALL and
male control subjects (OR = 3.73: 1.19-10.3). This was absent in
girls with c-ALL and in four other pairs of DQAIDQBI alleles
known to be in linkage disequilibrium.
HLA-DQ polymorphic amino acids
We previously found that c-ALL was associated with the absence
of DQBI alleles coding for aspartic acid (Asp) at position 57 of
DQB1 (DQOlAsp57-: Dearden et al. 1996). As DQalArg52+.
DQO1Asp57- is a susceptibility haplotype in juvenile insulin-
dependent diabetes (IDDM: Tosi et al. 1994). we analysed its
frequency in c-ALL. We found no association with c-ALL (data
not shown). Further analysis revealed an increased frequency of
serine at position 52 (aSer52) ofDQA1. and valine at position 57
(PVal57) of DQB1 (i.e. aSer52.I3Val57) in c-ALL (Table 3:
OR = 2.34: 1.07-49.7). This was confined to boys (OR = 4.18:
1.41-11.03) and was absent from girls with c-ALL (OR = 0.83:
0.25-3.0).
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Table 2 Frequency of co-occurring DOAl and DCB1 alleles in childhood common ALL
Total Male Female
DQA1, DOBlP
alleles c-ALL Infant ORc 95% C c-ALL Infant OR 95% Ca c-ALL Infant OR 95% Cl
O1O1,'0501 30.0' 17.3 2.04' 0.91-4.45 36.8 13.5 3.73 1.19-10.3 18.2 21.1 0.83 0.25-3.0
'0102,'0602 11.7 16.0 0.69 0.27-1.85 5.3 16.2 0.28 0.08-1.39 22.7 15.8 1.56 0.46-5.39
'03,'0302 11.7 12.0 0.96 0.36-2.66 13.2 10.8 1.25 0.34-4.39 9.1 13.2 0.66 0.17-3.29
'0501',0201 23.3 40.0 045e 0.22-0.97 23.7 37.8 0.51 02-1.37 22.7 42.1 0.40 0.14-1.31
'0501.'0301 20.0 16.0 1.31 0.56-3.08 18.4 16.2 1.16 0.37-3.56 22.7 15.8 1.56 0.46-5.39
aCo-occurring DQA1 and DQB1 alleles. figures are % allele frequencies. COR, odds ratios; 95% Cl. 95% confidence intervals. dDQA1O10O1/'004 DQB1'0501:
total c-ALL vs total control subjects: two-sided Fisher's P= 0.12. Male c-ALL vs male control subjects: two-sided Fisher's P= 0.03. Female c-ALL vs female
control subjects, not significant eDQAX1'0501,DQB1'0201: total c-ALL vs total control subjects: two-sided Fisher's P= 0.06. Male c-ALL vs male control
subjects. and female c-ALL vs female control subjects, not significant.
Table 3: Frequency of c-ALL patients and control subjects with alees coding serine at posion 52 of DOAl and valine at postion 57 of DB1
Total Males Females
DMal, DQ*1
heterodimersa c-ALL Infants OR' 95% Ca c-ALL Infants OR 95% Ca c-ALL Infants OR 95% Ca
aSer52+,PVal57+ 35.0' 18.7 2.34d1 1.07-4.97 44.7c 16.2 4.18 1.41-11.03 18.2c 21.1 0.83 0.25-3.00
aSer52+,PVal57- 51.7 49.3 1.09 0.68-2.71 44.7 54.1 0.68 0.29-1.68 63.6 44.7 2.16 0.74-5.90
aSer52-,PVal57+ 0 0 - - 0 0 - - 0 0 -
aSer52-,PVal57- 13.3 32.0 0.32 0.15-0.80 10.5 29.7 0.27 0.09-0.96 18.2 34.2 0.42 0.14-1.50
rwe= 60 75 38 37 22 38
aDQa1 serine52 is coded by DOA1'0101/0104,'0102,'0103 DQ$1 valine57 is coded by DQB1'0501, '0604-6, 8and 9. Combinations of amino acids are those
where the specific codon is either present (+) or absent (-); (i.e. some other codon is present). bFigures are % frequency of patients and control subjects with
each DOal,DQ1 heterodimer. cOR, odds ratios: 95% Cl, 95% confidence intervals. dDQalSer52+, DQ130 Val57+: total c-ALL vs total infant control subjects:
two-sided Fisher's P= 0.05. Male c-ALL vs male control subject: two-sided Fisher's P= 0.01. Female c-ALL vs female control subjects: two-sided Fsher's
P = 1.06. en = total number of subjects (i.e. c-ALL or control subjects) in each group (total, male or female).
The significance of these associations disappears following
correction for the number of alleles tested We therefore performed
simulations based on allele and haplotype frequencies in the present
study to estimate case and control sample sizes required to obtain
statistical significance. We assumed 90% powerto detect aP =0.005
in a two-sided test, before correction for the number of alleles in
equal numbers ofcases and control subjects. ForDQAJ*01011*0104.
the total number ofpatients and control subjects is 475. and forboys
it is 181. For DQAI*0101/*0104,DQBI*0501 haplotypes. total
patient and control series require 388 in each group whereas boys
require 122 patients and controls.
DISCUSSION
Evidence suggesting that the same HLA class II polymorphic
sequences contribute both to the binding ofantigenic peptides and
disease susceptibility (Hammer et al. 1995: Kwok et al. 1996)
suggests that an HLA-DQAJDQBI haplotype association with
childhood c-ALL could be construed as evidence of an infectious
aetiology. In this study we found an increased frequency of
DQAI*01011*0104. and a deficit of DQAI*0201 in c-ALL.
suggesting roles in susceptibility and resistance to c-ALL respec-
tively. Further analysis showed that DQAI*01011*0104 was
increased in boys but not girls with c-ALL. a finding which would
not have been expected by chance alone. Analysis ofpatients and
control subjects classified by the presence or absence of
DQAI*01011*0104 and DQBI*0501 showed that an increase in
this 'haplotype' in patients was confined to boys. This haplotype
(and certain others) encodes DQctSer52 and DQIVal57. Both
amino acids were increased in c-ALL. but this was also confined to
male patients. These results need to be treated with caution as they
were not corrected for the numberofalleles. However. we used the
results to simulate the number of cases and control subjects
required to repeat the study in an independent series.
The patients in this study were an unselected series with c-ALL.
in which 63% were boys and 37% were girls (M:F 1.73:1). Analysis
of 199 cases of childhood c-ALL in the Manchester Children's
Tumour Registry (MCTR) for 1983-94 showed 118 boys and 81
girls (M:F 1.5:1). suggesting that the male excess was not due to
chance. McKinney et al (1993) found no difference in the rate of
c-ALL in boys and girls aged 1-9 in a UK study. but Buckley et al
(1994) reported an M:F of 1.2:1 in 312 cases of c-ALL in a US
study. We found no evidence that inclusion of only verified c-ALL
patients. and exclusion of unclassified ALL favoured boys over
girls. There was no difference in the age or gender of patients
donating and not donating blood samples to the study.
The DQAI SSO probes used here define polymorphisms
confined to exon 2 but do not distinguish between DQAI*0101
and *0104. These alleles differ for single base substitutions in
codons 2 (exon 1) and 199 (exon 4) (Yasunaga et al. 1996). It
remains to be seen whether the difference between *0101 and
*0104 has any influence on susceptibility to c-ALL.
Our results contrast with Dorak et al (1995) who used a restric-
tion fragment length polymorphism (RFLP)-based method to type
DQAI alleles in childhood ALL. They found no increase in DQAI-
JA in ALL. nor any difference between male and female patients
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typing for this allele. However. they found a significant increase in
allele 3 in male compared with female ALL patients. We found an
increase in DQA1*03. which was confined to boys with c-ALL.
However. there was no difference in patients and control subjects
typing for both DQAI*03 and DQBI*0302. which are in linkage
disequilibrium (Imanishi et al. 1992). Furthermore. there was no
increase in the frequency ofDQAI*03 homozygotes in c-ALL.
As DQA1 is tightly linked to DQBJ. the DQAI*0101/*0104
association with c-ALL could be explained by linkage disequilib-
rium with DQBI *0501. The present study confirms an increased
frequency of both alleles in boys with c-ALL. but not of other
DQAIJDQBI haplotypes. Our previous results showed a reduced
frequency of aspartic acid at position 57 in c-ALL (Dearden et al.
1996). suggesting similarities with the DQ~lAsp57- motif associ-
ated with IDDM (Tosi et al. 1994). However. analvsis of the
IDDM susceptibility haplotype DQalArg52.DQf1Asp57-
showed no evidence of a role in c-ALL.
HLA-DQAI *0101. 0102. 0103 and 0104 all code serine at posi-
tion 52. and DQBI*0501. 0604-06. 0608 and 0609 code valine at
position 57 (see Marsh). However. we found that only one haplo-
type. DQAI*0101/*0104-DQBI*0501. predominated in c-ALL.
Thirty per cent of c-ALLs compared with 17.3% of control
subjects had this haplotvpe. Analysed by gender. 36.8%7 ofmale c-
ALL compared with 13.5%c male control subjects expressed
DQotlSer52.DQIlVaI57 heterodimers. but there was no differ-
ence between female patients and controls subjects.
Gene transfection studies bv Kwok et al (1993) showed that the
expression of DQBI*0501-encoded a-chains is facilitated by
DQAI*0101 et-chains and is influenced by amino acids coded at
the 3' end of DQBJ. corresponding to positions 60 and 91 of the
DQIBl subunit. Furthermore. DQAI*0101-DQBI*0501 is one of
the most common DQAI-DQBI haplotypes in the UK population
(Doherty et al. 1992) and the second most common haplotvpe in
French. Danish and Spanish populations (Imanishi et al. 1992).
The gene expression and population genetic data thus suggest that
the DQAI*0101.DQBI *0501 haplotype may have had a selective
advantage. possible by protecting against infectious diseases.
Our results sugaesting that susceptibility to c-ALL is increased
in boys with a common DQAIl-DQBJ haplotvpe could be
explained by- a greater contribution of DQalSer52IDQlVal57
peptide-binding motifs to the protection of boys against certain
types of childhood infection. There is increased susceptibility of
male children to infections (Washburn et al. 1965: Purtilo and
Sullivan. 1979)i. which suggests that certain HLA haplotvpes may-
counteract X-linked defects in immunity in boys (Immunological
Reviews. 1994). by promoting the efficiency of antigen presenta-
tion. If confirmed. our results would imply that a common DQAJ-
DQBJ haplotvpe that mayr increase resistance to infection in boys
has an important influence on susceptibility to childhood c-ALL.
This would be consistent with the predictions of the Greaves
hypothesis (Greaves. 1988: Greaves and Alexander. 1993). and
further suggests that the candidate infection involved in c-ALL
exhibits low- pathogenicity- but strong immunogenicity.
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